product
Eurofins Amatsigroup ǀ Your cDmo partner
Frédéric Gaussens from Eurofins Amatsigroup (CDMO) giving an overview of the services they provide...
List view / Grid view
Immunotherapy
news
Immunotherapy for metastatic or recurrent head and neck cancer
The KEYNOTE-048 study examined the use of immunotherapy with pembrolizumab rather than the standard treatment using cetuximab for head and neck cancer...
news
Immunotherapy success for triple-negative breast cancer
A combination of chemotherapy and immunotherapy could soon be used in NHS hospitals for triple-negative breast cancer to extend patient survival...
news
Researchers find combination can enhance ipilimumab immunotherapy
Anti-CTLA-4 treatment triggers immune-suppressing EZH2 on T cells; clinical trial open...
news
Immunotherapy using tumour infiltrating lymphocytes for metastatic cancer
A novel approach to immunotherapy developed by researchers at the National Cancer Institute (NCI) has led to the complete regression of breast cancer in a patient who was unresponsive to all other treatments.
news
DNA-based vaccine treatment for colorectal cancer to undergo first human study
Researchers hope immunotherapy will prevent against overactive immune response...
news
New cancer immunotherapy drugs rapidly reach patients after approval
The majority of patients eligible for cancer immunotherapy drugs known as checkpoint inhibitors received treatment within a few months of FDA approval, according to a new Yale-led study.
news
Vaccine suppresses peanut allergies in mice
Researchers aim to develop a new immunotherapy that could alter the immune reactions to food. The result: Extended relief from peanut allergies...
news
Simultaneous chemo and immunotherapy is effective in metastatic bladder cancer
Researchers have discovered that giving metastatic bladder cancer patients simultaneous chemotherapy and immunotherapy is safe and that patients whose tumours have certain genetic mutations...
news
Combination immunotherapy improves survival in mouse models of mesothelioma
Combined treatment with two cancer immunotherapy drugs significantly prolonged survival in aggressive cancer malignant mesothelioma...
news
T-VEC treatment shows promise for treating advanced stage liver tumours
Phase 1 data supports the use of image-guided therapy for difficult to treat cancer...
news
Antibiotics may impact cancer treatment efficacy
Improper use of antibiotics may have an unintended consequence of hampering cancer treatments...
news
Therapeutic gel shows promise against cancerous tumours
Researchers have developed a biodegradable hydrogel scaffold system to release chemotherapeutic and immunotherapeutic drugs at the tumour site...
news
FDA expands approval of Imfinzi to reduce the risk of NSCLC progression
The FDA has approved Imfinzi for the treatment of patients with stage III non-small cell lung cancer whose tumours are not able to be surgically removed and whose cancer has not progressed after treatment...
news
Rare melanoma type highly responsive to immunotherapy
Moffitt Cancer Center researchers have discovered that patients with desmoplastic melanoma are more responsive to immune-activating anti-PD-1/PD-L1 therapies than previously assumed.
